Published Date: 17 Mar 2023
A group of researchers from the annual meeting of the American Academy of Orthopedic Surgeons (AAOS) "analyzed the data and...
Read Full NewsQ3 2026 Recap: Psychiatry News and Updates
New cerebrospinal fluid biomarker data suggest shared LRRK2 pathway activation across sporadic and LRRK2-associated Parkinson disease, potentially informing biomarker development and therapeutic targeting.
Kristina Derrick, MD, explains how prior authorization and cost limit steroid-sparing care, and how dermatologists can document corticosteroid exposure.
Bhatia discusses 52-week extension data showing denifanstat sustained acne control with a favorable long-term safety profile, presented at EADV 2026.
1.
Health researchers discuss Medicaid cancer screening trends, best practices
2.
Quads, Frailty, and the Future: Evolving Frontline Strategies in Multiple Myeloma
3.
Approved BTK Inhibitor Without Covalent Bond for CLL.
4.
Genomic Newborn Screening Could Identify Childhood Cancer Predisposition
5.
AI-based breast cancer risk technology receives FDA breakthrough device designation
1.
Evolving Cancer Treatments: Innovations, Success Rates, and Mechanisms
2.
Innovative Solutions in Hematology for Specialists
3.
What Is Carboxyhemoglobin And How Can It Affect Your Health?
4.
Carboplatin Treatment: What You Need to Know About Side Effects and Efficacy
5.
Evidence-Based Insights in Oncology for Specialists
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
1.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
2.
Managing ALK+ NSCLC while Ensuring Long-Term Safety of the Patients
3.
ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis
4.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part III
5.
Efficient Management of First line ALK-rearranged NSCLC - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation